Eszopiclone: all 62 studies that test it

Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.

• Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep ApneaRecruitingNCT07332442Phase 3
• Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)RecruitingNCT07018557Phase 4
• Effects of Eszopiclone and Lemborexant in People With OSA With a Low Arousal Threshold Who Have Difficulty SleepingRecruitingNCT06928766Phase 2
• Endotypic Traits and Obstructive Sleep Apnea SurgeryRecruitingNCT05953610Phase 2
• Rescue Pharmacotherapy for OSARecruitingNCT05293600Phase 1/2
• Combination Drug-Therapy for Patients With Untreated Obstructive Sleep ApneaCompletedNCT04639193Phase 2Results posted
• Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSDCompletedNCT03937713Phase 4Results posted
• Safety and Efficacy of Chronic Hypnotic Use 2CompletedNCT02456532Phase 4Results posted
• Effects of Eszopiclone on Sleep and Memory in SchizophreniaCompletedNCT01641900Not applicableResults posted
• Eszopiclone for the Treatment of Posttraumatic Stress DisorderCompletedNCT01605253Phase 4Results posted
• The Effect of Eszopiclone on the Arousal Threshold in Sleep Apnea SyndromeCompletedNCT01102270Early Phase 1Results posted
• A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)CompletedNCT01055834Phase 1Results posted
• Effects of Daytime Eszopiclone Administration in Shift WorkersCompletedNCT00900159Not applicableResults posted
• Eszopiclone Treatment & Cortisol ResponsivityCompletedNCT00889200Phase 4Results posted
• Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated InsomniaCompletedNCT00857220Phase 3Results posted
• Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated InsomniaCompletedNCT00856973Phase 3Results posted
• Effects of Eszopiclone on Sleep-dependent Learning in SchizophreniaCompletedNCT00833547Not applicableResults posted
• The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and InsomniaCompletedNCT00826111Phase 4Results posted
• Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary SyndromeCompletedNCT00822679Phase 4Results posted
• Treatment of Insomnia in MigraineursCompletedNCT00812214Phase 4Results posted
• A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)CompletedNCT00770692Phase 3Results posted
• A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)CompletedNCT00770510Phase 2/3Results posted
• Treatment of Insomnia and Glucose MetabolismCompletedNCT00724282Phase 4Results posted
• Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With SchizophreniaCompletedNCT00645944Not applicableResults posted
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD SubjectsCompletedNCT00616655Phase 2Results posted
• Sleep Loss and Mechanisms of Impaired Glucose MetabolismCompletedNCT00555750Not applicableResults posted
• Study of Lunesta Versus Placebo for Sleep Problems Related to Smoking Cessation and ZybanTerminatedNCT00511134Phase 4Results posted
• Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home PatientsCompletedNCT00460993Phase 4Results posted
• Eszopiclone in the Treatment of Insomnia and FibromyalgiaCompletedNCT00392041Phase 4Results posted
• A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic InsomniaCompletedNCT00386334Phase 4Results posted
• Insomnia and Osteoarthritis StudyCompletedNCT00374556Not applicableResults posted
• Study of the Insomnia in Patients With Low Back PainCompletedNCT00365976Phase 4Results posted
• Effect of Eszopiclone on Sleep Disturbance and Pain in CancerCompletedNCT00365261Phase 4Results posted
• Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of EszopicloneCompletedNCT00324896Phase 3Results posted
• Improving Sleep and Psychological Functioning in People With Depression and InsomniaCompletedNCT00247624Phase 4Results posted
• Eszopiclone for Sleep Disturbance and Nightmares in Post-Traumatic Stress DisorderCompletedNCT00120250Phase 4Results posted
• Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISACompletedNCT06017921Phase 4
• Endotype-Targeted Therapy to Rescue OSA Patients Struggling With CPAP Adherence (TOP-CPAP)CompletedNCT05951023Phase 2
• Bioavailability of Eszopiclone 3.0 mg With Regards to Reference ProductCompletedNCT05349396Phase 1
• National Adaptive Trial for PTSD Related InsomniaCompletedNCT03668041Phase 3
• Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fed ConditionsCompletedNCT02322658Phase 1
• Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting ConditionsCompletedNCT02322645Phase 1
• Sleep Effectiveness and Insulin and Glucose HomeostasisTerminatedNCT01887691Phase 1
• Twelve Month Study of the Safety of Eszopiclone in Adult Subjects With InsomniaCompletedNCT01710631Phase 3
• A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of InsomniaCompletedNCT01100164Phase 3
• The Effect of Marijuana and Prescription Medications in Mood, Performance and SleepCompletedNCT00893269Phase 1
• Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive DisorderCompletedNCT00813735Phase 4
• Safety and Efficacy of Eszopiclone With Mild to Moderate Obstructive Sleep Apnea Syndrome (OSAS)CompletedNCT00685269Phase 2
• Brain Mechanisms and Targeting Insomnia in Major DepressionStatus unknownNCT00628914Phase 4
• Continuous Positive Airway Pressure (CPAP) Promotion And Prognosis - the Army Sleep Apnea Program (ASAP)CompletedNCT00612157Phase 4
• Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)CompletedNCT00594087Not applicable
• Ezopiclone Improves the Quality of Overnight PolysomnographyCompletedNCT00507117Phase 4
• A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and InsomniaCompletedNCT00435279Phase 3
• How do Sleeping Pills Affect Pain in the Brain?TerminatedNCT00414037Phase 4
• The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal WomenCompletedNCT00374192Not applicable
• Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy VolunteersCompletedNCT00368160Phase 1
• Effects of One Evening Dose of 3 mg Eszopiclone on Next Day Driving AbilityCompletedNCT00368056Phase 3
• A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive DisorderCompletedNCT00368030Phase 3
• Study of Eszopiclone Compared to Placebo on Daytime Function in Subjects With Insomnia Related to Rheumatoid ArthritisCompletedNCT00367965Phase 3
• Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/MenopauseCompletedNCT00366093Phase 3
• 6-Month Chronic Efficacy & Safety Study of Eszopiclone in Adult Subjects With Primary InsomniaCompletedNCT00352144Phase 3
• Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety DisorderCompletedNCT00235508Phase 4

← Eszopiclone overview